Coronavirus

Phase 3 EMPACTA Study: Tocilizumab Shows Efficacy in COVID-19 Associated Pneumonia

September 24, 2020

Tocilizumab (Actemra; Genentech) reduced the likelihood of needing mechanical ventilation in hospitalized patients with COVID-19 associated pneumonia.

FDA Issues EUA for First Point-of-Care COVID-19 Antibody Test

September 24, 2020

The Assure test is the only FDA authorized COVID-19 point-of-care serology test.

Johnson & Johnson’s COVID-19 Vaccine Candidate Enters Phase 3 Trial

September 23, 2020

Johnson & Johnson has launched its large-scale phase 3 trial for Janssen’s COVID-19 vaccine candidate.

Study Compares Clinical Features of COVID-19 and Seasonal Influenza

September 22, 2020

A new report illuminates the similarities and differences between COVID-19 and seasonal influenza.

Common Cold Infection May Trigger Antiviral Defenses Against Influenza

September 22, 2020

A study evaluated interference between rhinovirus and influenza A virus during the 2009 pandemic.

Study Evaluates Famotidine Use in Hospitalized COVID-19

September 21, 2020

The study evaluated COVID-19 patients within the epicenter of the COVID-19 pandemic in the United States.

Coronavirus News Roundup: US Unveils COVID-19 Vaccine Rollout Strategy, AstraZeneca Vaccine Trial Resumes

September 18, 2020

Here's this week's coronavirus-related news you should know.

US COVID-19 Vaccine Rollout Strategy Unveiled

September 18, 2020

The Trump administration released its COVID-19 vaccine strategy, with pharmacies among the list of suggested providers for distribution.

Study: Use of Azithromycin With QT Prolonging Drugs Linked to Cardiac Events

September 18, 2020

A study compared cardiac events associated with azithromycin versus amoxicillin.

Expert Interview: Medication Adherence Amid COVID-19

September 15, 2020

Heidi Polek, strategic program manager at DrFirst, discusses with Drug Topics the impact that the COVID-19 pandemic is having on chronic conditions and medication adherence.